141 related articles for article (PubMed ID: 28375935)
1. Estriol: emerging clinical benefits.
Ali ES; Mangold C; Peiris AN
Menopause; 2017 Sep; 24(9):1081-1085. PubMed ID: 28375935
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of vaginal estriol and progesterone in postmenopausal women with atrophic vaginitis.
Chollet JA; Carter G; Meyn LA; Mermelstein F; Balk JL
Menopause; 2009; 16(5):978-83. PubMed ID: 19390463
[TBL] [Abstract][Full Text] [Related]
3. [The role of estriol in therapy of urogenital disorders in postmenopausal women].
Perepanova TS; Khazan PL
Urologiia; 2007; (3):102-4, 107. PubMed ID: 17722629
[No Abstract] [Full Text] [Related]
4. Efficacy of low-dose intravaginal estriol on urogenital aging in postmenopausal women.
Dessole S; Rubattu G; Ambrosini G; Gallo O; Capobianco G; Cherchi PL; Marci R; Cosmi E
Menopause; 2004; 11(1):49-56. PubMed ID: 14716182
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of estriol replacement therapy for climacteric women.
Yang TS; Tsan SH; Chang SP; Ng HT
Zhonghua Yi Xue Za Zhi (Taipei); 1995 May; 55(5):386-91. PubMed ID: 7641124
[TBL] [Abstract][Full Text] [Related]
6. Low-dose, vaginally administered estrogens may enhance local benefits of systemic therapy in the treatment of urogenital atrophy in postmenopausal women on hormone therapy.
Palacios S; Castelo-Branco C; Cancelo MJ; Vázquez F
Maturitas; 2005 Feb; 50(2):98-104. PubMed ID: 15653006
[TBL] [Abstract][Full Text] [Related]
7. Review of the endometrial safety during intravaginal treatment with estriol.
Vooijs GP; Geurts TB
Eur J Obstet Gynecol Reprod Biol; 1995 Sep; 62(1):101-6. PubMed ID: 7493689
[TBL] [Abstract][Full Text] [Related]
8. Effects of intravaginal estriol and pelvic floor rehabilitation on urogenital aging in postmenopausal women.
Capobianco G; Donolo E; Borghero G; Dessole F; Cherchi PL; Dessole S
Arch Gynecol Obstet; 2012 Feb; 285(2):397-403. PubMed ID: 21706345
[TBL] [Abstract][Full Text] [Related]
9. Estriol: safety and efficacy.
Head KA
Altern Med Rev; 1998 Apr; 3(2):101-13. PubMed ID: 9577246
[TBL] [Abstract][Full Text] [Related]
10. Estriol treatment ameliorates disease in males with experimental autoimmune encephalomyelitis: implications for multiple sclerosis.
Palaszynski KM; Liu H; Loo KK; Voskuhl RR
J Neuroimmunol; 2004 Apr; 149(1-2):84-9. PubMed ID: 15020068
[TBL] [Abstract][Full Text] [Related]
11. Beneficial aspect of oral estriol as hormone replacement therapy: consideration on bone and lipid metabolism.
Kika G; Izumi S; Mori A; Murano T; Suzuki T; Cai LY; Nakamura E; Goya K; Maeda H; Uchida N; Shida M
Tokai J Exp Clin Med; 2009 Sep; 34(3):92-8. PubMed ID: 21319007
[TBL] [Abstract][Full Text] [Related]
12. The bioidentical hormone debate: are bioidentical hormones (estradiol, estriol, and progesterone) safer or more efficacious than commonly used synthetic versions in hormone replacement therapy?
Holtorf K
Postgrad Med; 2009 Jan; 121(1):73-85. PubMed ID: 19179815
[TBL] [Abstract][Full Text] [Related]
13. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
Stephenson K; Neuenschwander PF; Kurdowska AK
Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
[TBL] [Abstract][Full Text] [Related]
14. Estrogen replacement therapy in postmenopausal women: a study of the efficacy of estriol and changes in plasma gonadotropin levels.
Ushiroyama T; Sakai M; Higashiyama T; Ikeda A; Ueki M
Gynecol Endocrinol; 2001 Feb; 15(1):74-80. PubMed ID: 11293929
[TBL] [Abstract][Full Text] [Related]
15. [Basic principles of hormone replacement therapy in the postmenopause].
Dören M
Ther Umsch; 2000 Oct; 57(10):628-34. PubMed ID: 11081374
[TBL] [Abstract][Full Text] [Related]
16. Effect of oral estriol on urogenital symptoms, vaginal cytology, and plasma hormone level in postmenopausal women.
Manonai J; Theppisai U
J Med Assoc Thai; 2001 Apr; 84(4):539-44. PubMed ID: 11460966
[TBL] [Abstract][Full Text] [Related]
17. The effects of selective estrogen receptor modulator treatment following hormone replacement therapy on elderly postmenopausal women with osteoporosis.
Hayashi T; Ina K; Maeda M; Nomura H
Nitric Oxide; 2011 May; 24(4):199-203. PubMed ID: 21513812
[TBL] [Abstract][Full Text] [Related]
18. Obstetrical complications associated with abnormal maternal serum markers analytes.
Gagnon A; Wilson RD;
J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
[TBL] [Abstract][Full Text] [Related]
19. [Transvaginal administration of estriol in postmenopausal urogynecological disorders].
Di Stefano L; Patacchiola F; Moscarini M
Minerva Ginecol; 1993 Nov; 45(11):551-6. PubMed ID: 8121603
[TBL] [Abstract][Full Text] [Related]
20. Use of vaginal estrogen in Danish women: a nationwide cross-sectional study.
Meaidi A; Goukasian I; Lidegaard O
Acta Obstet Gynecol Scand; 2016 Mar; 95(3):280-4. PubMed ID: 26646469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
